Deals14 Jan 2025, 03:22 am
Piramal Enterprises to Receive USD 140 Million from Deferred Consideration in Subsidiary Sale
AI Summary
Piramal Enterprises Ltd. has announced that it will receive an estimated amount of USD 140 million from the sale of its step-down subsidiary, Piramal Imaging SA, to Alliance Medical Acquisitionco Limited. The consideration is part of the deferred consideration agreed upon in 2018, which is contingent on the future profits of the Imaging Group. The company may also receive further amounts up to a maximum of USD 200 million in subsequent years. The transaction is expected to be completed in FY 2026.
Key Highlights
- Piramal Enterprises to receive USD 140 million from the sale of Piramal Imaging SA
- Consideration is part of the deferred consideration agreed upon in 2018
- Further amounts up to USD 200 million may be received in subsequent years
- Transaction expected to be completed in FY 2026
- Not a related party transaction